Back

Prognostic impact of angiographically determined diffuse phenotype in functionally non-significant coronary stenosis

30 August 2025 (12:10 - 12:20)
Organised by: Logo
Congress Presentation Part of: Atypical coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Hidekuni Kirigaya

Yokohama City University Medical Center, Yokohama (Japan)

5 More presentations in this session

Presentation thumbnail
Long-term interval surveillance of kawasaki disease and associated coronary artery lesions using advanced coronary imaging
Doctor F. Tseng (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Prognostic effect of prediabetes defined by different criteria in patients with moderate-to-severe coronary artery calcification: a prospective cohort study
Doctor E. Xie (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Long-term clinical outcomes in patients with coronary artery spasm according to first responsive dose of intracoronary acetylcholine
Doctor M. Susanti (Jawa Timur, ID)
Abstract Slides Video
Presentation thumbnail
Characterizing premature myocardial infarction: clinical, lipid, and behavioral insights from the FRENCHIE Cohort
Professor J. Silvain (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction endotypes and clinical outcomes in patients with ischemia and no obstructive coronary arteries: A meta-analysis
Doctor A. Sakalidis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Atypical coronary syndromes
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 12:10 CET
You may be interested in
thumbnail
Congress Session
Atypical coronary syndromes
thumbnail
Congress Session
Functional testing in coronary artery disease
thumbnail
Congress Presentation
Is it safe to defer revascularisation in asymptomatic patients with chronic coronary syndrome with FFR-CT positive stenoses?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources